A Repository to Study Host-Microbiome Interactions in Health and Disease
2 other identifiers
observational
600
1 country
1
Brief Summary
Background: The microbiome is the bacteria and other microorganisms that live inside and on the body. The microbiome is important for our health. Researchers study how the microbiome help people stay healthy. They study how the microbiome affects the body when people get sick. To do this research, they need samples of the microbiome living on the bodies of many people. The purpose of this natural history study is to collect microbiome samples in a repository. These samples will be used for future research. Objective: To collect microbiome samples from the body that can be used for future research. Eligibility: People of any age. Only those older than 3 years will be seen at the NIH clinic. Design: Participants will fill out a questionnaire. Topics will include their medical history and foods they eat. Participants will be asked to give 1 or more of the following: Stool, urine, saliva, vaginal fluid, and breastmilk. These samples can be collected at home and sent to the researchers. Cells from participants cheek, nose, mouth, skin, rectum, and/or vagina. The cells may be collected by rubbing the area with a sterile cotton swab. These procedures can also be done at home. Blood. Blood may be drawn using a needle inserted into a vein in the arm. For young children, blood may be collected by a prick on the heel or finger. Intestinal tissue samples. These may be collected from participants who are having an endoscopy or colonoscopy for other reasons. Skin tissue samples. These may be collected from participants who are having biopsies for other reasons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2022
CompletedStudy Start
First participant enrolled
March 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2032
April 1, 2026
October 1, 2025
8.8 years
December 15, 2022
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Collection of biological specimens to assess host microbiome response
To provide samples for use in secondary research for evaluation of assay validation, optimization of techniques for collection, storage, processing and analyzing samples, control samples for research tests in other studies, and identification of potential targets from which clinical trials can be designed to better understand or mitigate microbiome associated diseases
Through End of Study
Study Arms (1)
Single Cohort
Participants aged \>0 years with no upper age limit, both healthy volunteers and those with previously known and unknown disease states
Eligibility Criteria
People of all ages who meet study criteria.
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Aged \>0 years. Only participants \>3 years old will be seen at the NIH CC.
- Willing to allow biological samples and data to be stored for future research.
- Willing to provide at least one of the requested biospecimens.
You may not qualify if:
- An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.
- For additional gastrointestinal and skin biopsies only, individuals on blood thinners unless they have already been stopped for the procedure.
- For additional gastrointestinal biopsies only, individuals who have a history of gastrointestinal perforation with endoscopic biopsies will be excluded from the collection of additional gastrointestinal biopsies for the repository.
- For additional gastrointestinal biopsies only, healthy children (\<18 years old).
- For skin biopsies only, individuals who have a history of keloid formation.
- For vaginal swabs and vaginal fluid only, individuals who have not started menses.
- For breast milk only, non-lactating individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Suchitra K Hourigan, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2022
First Posted
December 19, 2022
Study Start
March 9, 2023
Primary Completion (Estimated)
January 1, 2032
Study Completion (Estimated)
January 1, 2032
Last Updated
April 1, 2026
Record last verified: 2025-10-01